Predictive performance of NEWS and qSOFA in immunocompromised sepsis patients at the emergency department
Infection · 2024-10 · 52 (5) · 1863-1873
DOI: 10.1007/s15010-024-02247-4 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Infection, online erschienen am 12.04.2024. Verfasst von Lisanne Boekhoud und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, EB70, 9700 RB, Groni…. Hauptthemen laut MEDLINE: Sepsis, Immunocompromised Host, Emergency Service, Hospital, Organ Dysfunction Scores. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Purpose
Sepsis has a high incidence and a poor prognosis. Early recognition is important to facilitate timely initiation of adequate care. Sepsis screening tools, such as the (quick) Sequential Organ Failure Assessment ((q)SOFA) and National Early Warning Score (NEWS), could help recognize sepsis. These tools have been validated in a general immunocompetent population, while their performance in immunocompromised patients, who are particularly at risk of sepsis development, remains unknown.
Methods
This study is a post hoc analysis of a prospective observational study performed at the emergency department. Inclusion criteria were age ≥ 18 years with a suspected infection, while ≥ two qSOFA and/or SOFA criteria were used to classify patients as having suspected sepsis. The primary outcome was in-hospital mortality.
Results
1516 patients, of which 40.5% used one or more immunosuppressives, were included. NEWS had a higher prognostic accuracy as compared to qSOFA for predicting poor outcome among immunocompromised sepsis patients. Of all tested immunosuppressives, high-dose glucocorticoid therapy was associated with a threefold increased risk of both in-hospital and 28-day mortality.
Conclusion
In contrast to NEWS, qSOFA underestimates the risk of adverse outcome in patients using high-dose glucocorticoids. As a clinical consequence, to adequately assess the severity of illness among immunocompromised patients, health care professionals should best use the NEWS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, EB70, 9700 RB, Groningen, The Netherlands.
- Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
- Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, EB70, 9700 RB, Groningen, The Netherlands. h.r.bouma@umcg.nl.
- Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. h.r.bouma@umcg.nl.
Zitieren
APA
Boekhoud, L., Schaap, H. M. E. A., Huizinga, R. L., Olgers, T. J., Ter Maaten, J. C., Postma, D. F., & Bouma, H. R. (2024). Predictive performance of NEWS and qSOFA in immunocompromised sepsis patients at the emergency department. Infection, 52(5), 1863-1873. https://doi.org/10.1007/s15010-024-02247-4
Vancouver
Boekhoud L, Schaap HMEA, Huizinga RL, Olgers TJ, Ter Maaten JC, Postma DF, et al. Predictive performance of NEWS and qSOFA in immunocompromised sepsis patients at the emergency department. Infection. 2024;52(5):1863-1873. doi:10.1007/s15010-024-02247-4
BibTeX
@article{Boekhoud2024,
author = {Boekhoud, Lisanne and Schaap, Helena M E A and Huizinga, Rick L and Olgers, Tycho J and Ter Maaten, Jan C and Postma, Douwe F and Bouma, Hjalmar R},
title = {Predictive performance of NEWS and qSOFA in immunocompromised sepsis patients at the emergency department},
journal = {Infection},
year = {2024},
volume = {52},
number = {5},
pages = {1863--1873},
doi = {10.1007/s15010-024-02247-4}
}
EUVIMED